Genetics in Medicine - Abstract of article: Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk

full-text ►
Genetics in Medicine - Abstract of article: Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk

Article

Genetics in Medicine (2011) 13, 349–355; doi:10.1097/GIM.0b013e3182091ba4

Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk

Douglas E Levy^1,2,3, Stacey D Byfield⁴, Catherine B Comstock⁵, Judy E Garber^3,6, Sapna Syngal^3,6,7, William H Crown⁴ and Alexandra E Shields^1,2,3

1. ¹arvard/MGH Center for Genomics, Vulnerable Populations and Health Disparities, Boston, Massachusetts
2. ²Mongan Institute for Health Policy, Massachusetts General Hospital, Boston, Massachusetts
3. ³Department of Medicine, Harvard Medical School, Boston, Massachusetts
4. ⁴i3 Innovus, Medford, Massachusetts
5. ⁵Independent Consultant, Winchester, Massachusetts
6. ⁶Division of Population Science, Dana-Farber Cancer Institute, Brookline, Massachusetts
7. ⁷Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts
8. ⁸i3 Innovus, Ann Arbor, Michigan.

Correspondence: Alexandra E. Shields, PhD, Harvard/MGH Center for Genomics, Vulnerable Populations, and Health Disparities, 50 Staniford Street, 9th floor, Boston, MA 02114. E-mail: ashields@partners.org.

Received 10 August 2010; Accepted 30 November 2010; Published online 23 February 2011.

Disclosure: The authors declare no conflict of interest.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.geneticsinmedicine.org).